# Upadacitinib for Moderate to Severe Atopic Dermatitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/upadacitinib-for-moderate-to-severe-atopic-dermatitis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | F.J. Navarro‐Triviño,Sara Alcantara‐Luna,J.J. Domínguez-Cruz,Manuel Galán‐Gutiérrez,Ricardo Ruíz‐Villaverde,J Rodríguez,José Carlos Armario Hita |
| Citations | 15 |
| DOI | 10.2217/imt-2023-0037 |
| Fields | Immunology and Microbiology,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4376871068 |
| PMID | 37194577 |
| Type | article |
| Year | 2023 |

## Paper authors

- [J.J. Domínguez-Cruz](https://scholariq.org/researchers/j-j-dominguez-cruz/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Pharmacological Effects of Natural Compounds](https://scholariq.org/topics/pharmacological-effects-of-natural-compounds/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.